(Q44663178)

5 December 2017

Production of Antibodies to Cellular Antigens by EBV-Transformed Lymphocytes from Patients with Urinary Bladder Carcinoma (English)

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.1984.TB01025.X

4 August 2023

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.1984.TB01025.X

4 August 2023

6

Perlmann P

1 reference

5 December 2017

S. Paulie

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6095441

4 August 2023

M. L. Lundblad

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6095441

4 August 2023

Y. Hansson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6095441

4 August 2023

H. Koho

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6095441

4 August 2023

H. Ben-Aissa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6095441

4 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6095441

4 August 2023

publication date

1 November 1984

1 reference

full work available at URL

5 December 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-3083.1984.tb01025.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.1984.TB01025.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-3083.1984.tb01025.x/fullpdf

4 August 2023

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.1984.TB01025.X

Scandinavian Journal of Immunology

4 August 2023

published in

1 reference

5 December 2017

20

1 reference

5 December 2017

5

1 reference

5 December 2017

461-470

1 reference

Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein–Barr virus-induced B-cell lines

5 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1984.TB01025.X

Use of Epstein-Barr virus-transformed B cell lines for the generation of immunoglobulin-producing human B cell hybridomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1984.TB01025.X

Production of human hybridomas secreting antibodies to measles virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1984.TB01025.X

Properties and usefulness of the original K-562 human myelogenous leukemia cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1984.TB01025.X

Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1984.TB01025.X

Human hybridomas from malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1984.TB01025.X

EB virus-induced B lymphocyte cell lines producing specific antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1984.TB01025.X

A simple method for the isolation and purification of total lipides from animal tissues

21 January 2018

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.1984.TB01025.X

Humoral and cellular immune reactions against tumor cells in patients with urinary bladder carcinoma. Correlation between direct and antibody-dependent cell-mediated cytotoxicity

4 August 2023

8

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.1984.TB01025.X

Human antibody to OFA-I, a tumor antigen, produced in vitro by Epstein-Barr virus-transformed human B-lymphoid cell lines

4 August 2023

9

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.1984.TB01025.X

The lipid nature of a tumour-associated autoantigen from a chemically induced rat hepatoma

4 August 2023

11

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.1984.TB01025.X

Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity

4 August 2023

15

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.1984.TB01025.X

Cancer Immunology, Immunotherapy

4 August 2023

16

author name string

Paulie S.

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.1984.TB01025.X

Serological analysis of cell surface antigens of malignant human brain tumors

4 August 2023

19

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.1984.TB01025.X

A simple radioimmunoassay to determine binding of antibodies to lipid antigens

4 August 2023

23

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.1984.TB01025.X

Lymphocyte-mediated lysis of tumor cellsin vitro (ADCC), induced by serum antibodies from patients with urinary bladder carcinoma or from controls

4 August 2023

25

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.1984.TB01025.X

Cytotoxicity in vitro of blood lymphocytes from bladder cancer patients and controls to allogeneic or autologous tumor cells derived from established cell lines or short-term cultures

4 August 2023

27

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.1984.TB01025.X

Quantitative comparison of Epstein-Barr virus receptor expression on sIgM and sIgG cell lines and B-cell lymphoma biopsies

4 August 2023

30

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.1984.TB01025.X

4 August 2023

Identifiers

1 reference

5 December 2017

1 reference